All News

The American Diabetes Association's chief scientific and medical officer said the results are important to families at risk of type 1 diabetes.

The head of AHIP sat down with a senator and 3 health care executives for a conversation about payment and access issues at the organization's 2021 Institute and Expo Online.

Yescarta, the first and only approved chimeric antigen receptor T-cell therapy for these patients, was shown to achieve durable responses in a majority of patients and reduced the risk of death compared with other treatments.

Robert A. Gabbay, MD, PhD, the chief science and medical officer at the American Diabetes Association (ADA) offers insights on trial results and sessions to be presented at this year's ADA Scientific Sessions, taking place virtually June 25-29, 2021.

Validity assessments revealed that 2 algorithms utilizing administrative claims data and electronic medical records were accurate at identifying moderate and severe events signaling acute exacerbation of chronic obstructive pulmonary disease (AECOPD).

The average US life expectancy decreased by nearly 2 years from 2018 to 2020, with minority groups affected the most; the FDA will add a rare heart inflammation warning to fact sheets for the Pfizer and Moderna COVID-19 vaccines; a series of expansions to the Medicaid safety-net program is reportedly in consideration.

Children whose sleep apnea persist into adolescence have a 3-fold increased risk of high blood pressure and face an elevated risk of heart disease.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Alcohol abuse, obesity, and the use of systemic therapies instead of biologics were all linked with poor response among individuals with psoriasis.

At a session of AHIP 2021 Institute and Expo Online, the head of North Carolina's health and human services department and a health equity policy advisor in the Biden administration discussed how collecting and using data to achieve health equity is ultimately a policy decision.

Clinical trials and postmarketing surveillance suggest secukinumab has a favorable safety profile and low rates of discontinuation. A new study evaluated those metrics in a real-world setting in axial spondyloarthritis (AxSpA) and psoriatic arthritis (PsA).

Research presented at the American Headache Society's 63rd Annual Scientific Meeting outlines the association between migraine and history of mild traumatic brain injury.

Christopher Arendt, PhD, head of the Oncology Therapeutic Area Unit at Takeda, discusses pathogenesis and characteristics of EGFR exon 20 mutations in metastatic non–small cell lung cancer (NSCLC).

A report from Xcenda showed that biosimilars for 8 blockbuster reference biologics have successfully kept drug prices from increasing by an average of 56%, restoring the possibility that biosimilars could achieve significant discounts despite facing several barriers to uptake.

Blue Cross Blue Shield aims to fight increasing drug prices with a new pharmacy solutions company; Anthony Fauci, MD, warns about the growing threat from the Delta variant; COVID-19–related death rates highest in Texas border counties.

Early intensive treatment was more efficacious at slowing disease accumulation in patients with relapsing-remitting multiple sclerosis (RRMS) vs initiating therapy with a moderate-efficacy disease-modifying treatment (DMT) prior to switching to a higher-efficacy DMT.

Occupational exposure to the herbicide paraquat was not found to be associated with a greater risk of Parkinson disease or increased risk of mortality related to other causes.

Older adults with chronic obstructive pulmonary disease (COPD) identified factors likely to encourage or discourage patients from utilizing different technologies to track and improve physical activity.

Robert A. Gabbay, MD, PhD, the chief science and medical officer at the American Diabetes Association (ADA), previews sessions to be presented at the ADA's 81st Scientific Sessions.

Michael D. Anestis, PhD, executive director of the New Jersey Gun Violence Research Center and associate professor at the Rutgers School of Public Health, discusses his research on firearm ownership and suicide, in addition to steps needed to help decrease rates of gun-inflicted suicide and gun violence in general.

Agility has long been a big buzzword, but its salience and importance has been growing. Gallup’s research on agility finds that there are 7 fundamental shifts common to highly agile leaders—driving these changes through a hospital can help significantly advance a culture of agility.

The Biden administration shifts its planned vaccine donation from 80 million to 55 million vaccines amid ongoing safety review of AstraZeneca doses; a CMS report indicates that nearly 10 million individuals enrolled in Medicaid and CHIP amid the pandemic; significantly more deaths by suicide are reported than combat deaths in the US military.

A recent study said superior laryngeal nerve (SLN) blocks are effective for treating neurogenic cough, which are coughs that continue and persist after other conditions are ruled out.

Adults with normal kidney function who have comorbid depression are more likely to experience a decline in kidney function and have mental and physical impairments from that decline.

New CMS changes aim to broaden coverage of continuous glucose monitoring (CGM) devices.

The national supply of blood is dropping to dangerously low levels nationwide; the Veterans Health Administration will offer gender-affirming surgeries to transgender veterans; several vulnerable states are spotlighted amid the spread of the more transmissible delta COVID-19 variant.

Women who endure migraine are more susceptible to the development of obstetric and postpartum complications when pregnant, according to study results.